Ohr Pharmaceutical Inc (37) | Business Finance (9)
Browse by Subcategory
Recent Contracts
-
Underwriting Agreement, dated as of April 22, 2021, by and among NeuBase Therapeutics, Inc. and RBC Capital Markets, LLC, Oppenheimer & Co. Inc. and Chardan Capital Markets LLC,...
(Filed With SEC on April 22, 2021)
-
Registration Rights Agreement, dated as of July 12, 2019, between the Company and the purchasers named in the signature pages thereto
(Filed With SEC on July 12, 2019)
-
Common Stock Purchase Agreement, dated as of July 12, 2019, between the Company and the purchasers named in the signatures pages thereto
(Filed With SEC on July 12, 2019)
-
Form of NeuBase Therapeutics, Inc. Warrant Certificate
(Filed With SEC on March 8, 2019)
-
Form of NeuBase Therapeutics, Inc. Note Purchase Agreement
(Filed With SEC on March 8, 2019)
-
Underwriting Agreement, dated as of April 28, 2020, by and between NeuBase Therapeutics, Inc. and Oppenheimer & Co. Inc. and BTIG, LLC, as representatives of the underwriters...
(Filed With SEC on April 29, 2020)
-
Form of NeuBase Therapeutics, Inc. Convertible Promissory Note
(Filed With SEC on March 8, 2019)
-
Restricted Stock Purchase Agreement, made as of September 6, 2018, by and between NeuBase Therapeutics, Inc. and Dietrich A. Stephan
(Filed With SEC on March 8, 2019)
-
Amendment to Restricted Stock Purchase Agreement, made as of December 26, 2018, by and between NeuBase Therapeutics, Inc. and Dietrich A. Stephan
(Filed With SEC on March 8, 2019)